Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)

China · Delayed Price · Currency is CNY

12.76

+0.15 (1.19%)

Jul 29, 2026, 3:00 PM CST

SHA:600557 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,247	3,293	3,898	4,864	4,351	3,649
Revenue Growth	-4.99%	-15.52%	-19.86%	11.79%	19.25%	20.34%
Gross Profit	2,304	2,332	2,833	3,610	3,137	2,625
Operating Income	242.65	249.06	293.24	409.53	399	320.11
Net Income	299.79	303.93	391.86	464.16	434.47	320.54
Earnings Per Share	0.53	0.54	0.68	0.80	0.75	0.56
EPS Growth	-8.72%	-20.59%	-15.00%	6.67%	33.93%	27.27%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	2,036	2,148	2,235	2,439	1,771	1,113
Total Debt	1.06	407.36	488.01	424.66	1.93	236.43
Net Cash (Debt)	2,035	1,741	1,747	2,014	1,769	877.01
Net Cash Growth	-5.01%	-0.36%	-13.27%	13.84%	101.75%	209.48%
Net Cash Per Share	3.60	3.09	3.03	3.47	3.05	1.53

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	599.55	610.59	702.49	972.32	995.94	908.3
Capital Expenditures	-612.87	-521.78	-476.69	-311.29	-211.09	-171.52
Free Cash Flow	-13.32	88.81	225.8	661.03	784.85	736.77
Free Cash Flow Growth	-	-60.67%	-65.84%	-15.78%	6.53%	44.24%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	70.97%	70.81%	72.69%	74.22%	72.11%	71.95%
Operating Margin	7.47%	7.56%	7.52%	8.42%	9.17%	8.77%
Pretax Margin	10.79%	10.83%	9.87%	9.21%	10.24%	9.00%
Profit Margin	9.23%	9.23%	10.05%	9.54%	9.99%	8.79%
FCF Margin	-0.41%	2.70%	5.79%	13.59%	18.04%	20.19%

Dividends

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Dividend Per Share	0.372	0.220
Dividend Per Share Growth	69.11%	-
Dividend Yield	1.85%	1.21%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	24.06	26.28	19.79	25.85	25.23	22.01
Forward PE	21.09	14.69	12.25	19.80	22.32	16.11
P/FCF Ratio	-	89.95	34.35	18.15	13.97	9.58
PS Ratio	2.23	2.43	1.99	2.47	2.52	1.93